Chronic Selective Endothelin A Receptor Antagonism Reduces Serum Uric Acid in Hypertensive Chronic Kidney Disease

被引：10

作者：

Dhaun, Neeraj ^{[1
,2
]}

Johnston, Neil R. ^{[1
]}

Goddard, Jane ^{[2
]}

Webb, David J. ^{[1
]}

机构：

[1] Univ Edinburgh, Clin Pharmacol Unit, British Heart Fdn, Ctr Res Excellence,Queens Med Res Inst, Edinburgh, Midlothian, Scotland

[2] Royal Infirm Edinburgh NHS Trust, Dept Renal Med, Edinburgh, Midlothian, Scotland

来源：

HYPERTENSION | 2011年 / 58卷 / 02期

关键词：

CARDIOVASCULAR RISK; BLOOD-PRESSURE; HYPERURICEMIA; ALLOPURINOL; PROGRESSION; MORTALITY; COHORT; LEVEL;

D O I：

10.1161/HYPERTENSIONAHA.111.175646

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：E11 / E12

页数：2

共 12 条

[1] The endothelin system and its antagonism in chronic kidney disease [J].

Dhaun, Neeraj ;

Goddard, Jane ;

Webb, David J. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04) :943-955

[2] Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease [J].

Dhaun, Neeraj ;

MacIntyre, Iain M. ;

Kerr, Debbie ;

Melville, Vanessa ;

Johnston, Neil R. ;

Haughie, Scott ;

Goddard, Jane ;

Webb, David J. .

HYPERTENSION, 2011, 57 (04) :772-+

[3] Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992 [J].

Fang, J ;

Alderman, MH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2404-2410

[4] Uric acid and cardiovascular risk [J].

Feig, Daniel I. ;

Kang, Duk-Hee ;

Johnson, Richard J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1811-1821

[5] Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension - A randomized trial [J].

Feig, Daniel I. ;

Soletsky, Beth ;

Johnson, Richard J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (08) :924-932

[6]

Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI [10.1053/j.ajkd.2004.06.006, 10.1016/S0272-6386(04)00934-5]

[7] Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions [J].

Kanbay, Mehmet ;

Ozkara, Adem ;

Selcoki, Yusuf ;

Isik, Bunyamin ;

Turgut, Faruk ;

Bavbek, Nuket ;

Uz, Ebru ;

Akcay, Ali ;

Yigitoglu, Ramazan ;

Covic, Adrian .

INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (04) :1227-1233

[8] Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men -: A prospective cohort study [J].

Niskanen, LK ;

Laaksonen, DE ;

Nyyssönen, K ;

Alfthan, G ;

Lakka, HM ;

Lakka, TA ;

Salonen, JT .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (14) :1546-1551

[9] Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis [J].

Raichlin, Eugenia ;

Prasad, Abhiram ;

Mathew, Verghese ;

Kent, Bailey ;

Holmes, David R., Jr. ;

Pumper, Geralyn M. ;

Nelson, Rebecca E. ;

Lerman, Lilach O. ;

Lerman, Amir .

HYPERTENSION, 2008, 52 (03) :522-528

[10] Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level [J].

Siu, YP ;

Leung, KT ;

Tong, MKH ;

Kwan, TH .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) :51-59

← 1 2 →